Compare Novavax Inc (NVAX) vs Waste Management, Inc. (WM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Waste Management, Inc. — how do they compare? Novavax Inc trades at $9.86 (market cap $1.62B), while Waste Management, Inc. trades at $217.2 (market cap $86.51B). The key difference: Waste Management, Inc. is far larger — about 53.4× Novavax Inc's market cap, and Waste Management, Inc. pays a 1.75% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | WM | |
|---|---|---|
Market Cap | $1.62B | $86.51B |
Sector | Health | Industrials |
52-Week High | $11.19 | $246.51 |
52-Week Low | $6.22 | $196.77 |
Enterprise Value | $1.20B | $109.31B |
Dividend Yield | — | 1.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $10.19, down 0.29% today, with a bullish technical signal from moving averages but overbought RSI levels. Recent Q2 2026 earnings beat expectations, and the company raised its 2026 revenue outlook. Key developments include regulatory approvals for its updated COVID-19 vaccine in the U.S., EU, and Japan for the 2026-2027 season, alongside ongoing partnerships with Sanofi and Pfizer.
The outlook is mixed: strong analyst buy ratings (73.9%) and partnership milestones offer upside, but negative net income margins and cash flow challenges pose risks. Investors should weigh the potential from vaccine demand and adjuvant platform royalties against financial sustainability concerns and competitive pressures in the biotech sector.
WM trades at $217.78, down 0.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported mixed Q2 2026 earnings, beating EPS estimates at $2.02 versus $1.98 expected, but missed Q4 2025. Revenue grew to $25.20B in 2025, with a net income margin of 11.12%. Recent news highlights CEO transition and strong institutional buying, including a 26,113.1% position increase by California State Teachers Retirement System in Q2 2026.
Outlook remains positive with a consensus price target of $263.43, implying 21% upside, supported by steady waste demand and sustainability investments. Risks include high debt levels, with a debt-to-asset ratio of 49.97% in 2025, and valuation concerns at a P/E of 30.8. The stock offers a dividend yield from recent payouts, but investors face execution risks amid leadership changes and economic sensitivity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Waste Management, Inc.
Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
Read more on WM →
